Cite
HARVARD Citation
Boland, B. et al. (2022). Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies. Clinical and translational gastroenterology. 13 (4), pp. e00484-. [Online].